Search

everythinglearnresearchcommunity

for

Search:↓

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

The Flo app showed that bloating, high cholesterol and glucose levels are common in women with Polycystic ovary syndrome (PCOS), and these symptoms increase with body mass index (BMI), suggesting a need to refine PCOS diagnosis criteria.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Alopecia patients have less GPER-1, which might affect hair loss.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Acne in women may indicate insulin resistance.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Testosterone treatment may affect heart response to stress in transgender men.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.